DÄ internationalArchiveReferences
References

Original article

Smoking Cessation Attempts and Common Strategies Employed

Dtsch Arztebl Int 2020; 117: 7-13. DOI: 10.3238/arztebl.2020.0007

Kotz, D; Batra, A; Kastaun, S

1.Jha P, Ramasundarahettige C, Landsman V, et al.: 21st-century hazards of smoking and benefits of cessation in the United States. New Engl J Med 2013; 368: 341–50 CrossRef MEDLINE
2.Mons U: Tobacco-attributable mortality in Germany and in the German Federal States—calculations with data from a microcensus and mortality statistics. Gesundheitswesen 2011; 73: 238–46.
3.Kotz D, Böckmann M, Kastaun S: The use of tobacco, e-cigarettes, and methods to quit smoking in Germany—a representative study using 6 waves of data over 12 months (the DEBRA study). Dtsch Arztebl Int 2018; 115: 235–42 VOLLTEXT
4.Doll R, Peto R, Boreham J, Sutherland I: Mortality in relation to smoking: 50 years‘ observations on male British doctors. BMJ 2004; 328: 1519–27 CrossRef MEDLINE PubMed Central
5.Mons U, Brenner H: Demographic ageing and the evolution of smoking-attributable mortality: the example of Germany. Tob Control 2017; 26: 455–7 CrossRef MEDLINE
6.Schmidt HD, Rupprecht LE, Addy NA: Neurobiological and neurophysiological mechanisms underlying nicotine seeking and smoking relapse. Mol Neuropsychiatry 2018; 4: 169–89 CrossRef MEDLINE
7.Shiffman S, Patten C, Gwaltney C, et al.: Natural history of nicotine withdrawal. Addiction 2006; 101: 1822–32 CrossRef MEDLINE
8.Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB: Smoking withdrawal dynamics: I. Abstinence distress in lapsers and abstainers. J Abnorm Psychol 2003; 112: 3–13 CrossRef MEDLINE
9.Aguirre CG, Madrid J, Leventhal AM: Tobacco withdrawal symptoms mediate motivation to reinstate smoking during abstinence. J Abnorm Psychol 2015; 124: 623–34 CrossRef MEDLINE PubMed Central
10.Kotz D, West R: Explaining the social gradient in smoking cessation: It‘s not in the trying, but in the succeeding. Tob Control 2009; 18: 43–6 CrossRef MEDLINE
11.Heilert D, Kaul A: [Smoking behaviour in Germany—evidence from the SOEP. SOEPpapers on Multidisciplinary Panel Data Research]. Berlin: DIW 2017. www.diw.de/documents/publikationen/73/diw_01.c.563343.de/diw_sp0920.pdf (last accessed on 27 November 2017).
12.Batra A, Mann K: S3-Leitlinie „Screening, Diagnostik und Behandlung des schädlichen und abhängigen Tabakkonsums”. AWMF-Register Nr. 076–006. Düsseldorf: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) 2015 CrossRef
13.Andreas S, Batra A, Behr J, et al.: [Smoking cessation in patients with COPD]. S3-Guideline issued by the German Respiratory Society]. Pneumologie 2014; 68: 237–58 CrossRef MEDLINE
14.Stead Lindsay F, Lancaster T: Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 2012; 10: CD008286 CrossRef
15.van Rossem C, Spigt M, Viechtbauer W, Lucas AEM, van Schayck OCP, Kotz D: Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation: a randomized pragmatic trial in primary care. Addiction (Abingdon, England) 2017; 112: 2237–47 CrossRef MEDLINE
16.van den Brand FA, Nagelhout GE, Reda AA, et al.: Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev 2017; 9: CD004305 CrossRef MEDLINE PubMed Central
17.Kaper J, Wagena EJ, Willemsen MC, van Schayck CP: Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial. Addiction 2005; 100: 1012–20 CrossRef MEDLINE
18.Kaper J, Wagena EJ, Willemsen MC, van Schayck CP: A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence. Addiction 2006; 101: 1656–61 CrossRef MEDLINE
19.Kuntz B, Zeiher J, Hoebel J, Lampert T: Soziale Ungleichheit, Rauchen und Gesundheit. Suchttherapie 2016; 17: 115–23 CrossRef
20.Kuntz B, Kroll LE, Hoebel J, et al.: [Time trends of occupational differences in smoking behaviour of employed men and women in Germany : Results of the 1999–2013 microcensus]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018; 61: 1388–98 CrossRef MEDLINE
21.Lenzen-Schulte M: Tabakentwöhnung: Raucher schaffen es nicht allein. Dtsch Arztebl 2018; 115: A-1436–7 VOLLTEXT
22.Gemeinsamer Bundes­aus­schuss: Richtlinie des Gemeinsamen Bundes­aus­schusses zur Zusammenführung der Anforderungen an strukturierte Behandlungsprogramme nach § 137f Absatz 2 SGB V (DMP-Anforderungen-Richtlinie/DMP-A-RL). Bundesanzeiger (BAnz AT 22 März 2019 B5) 2019.
23.Kröger CB, Gomes de Matos E, Piontek D, Wenig JR: [Quitting attempts and utilisation of smoking cessation aids among smokers in Germany: results from the 2012 epidemiological survey of substance abuse]. Gesundheitswesen 2016; 78: 752–8 CrossRef MEDLINE
24.Kastaun S, Brown J, Brose LS, et al.: Study protocol of the German Study on Tobacco Use (DEBRA): a national household survey of smoking behaviour and cessation. BMC Public Health 2017; 17: 378 CrossRef MEDLINE PubMed Central
25.Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989; 84: 791–9 CrossRef MEDLINE
26.de Leon J, Diaz FJ, Becoña E, Gurpegui M, Jurado D, Gonzalez-Pinto A: Exploring brief measures of nicotine dependence for epidemiological surveys. Addic Behav 2003; 28: 1481–6 CrossRef
27.Chabrol H, Niezborala M, Chastan E, de Leon J: Comparison of the Heavy Smoking Index and of the Fagerstrom Test for Nicotine Dependence in a sample of 749 cigarette smokers. Addict Behav 2005; 30: 1474–7 CrossRef MEDLINE
28.Organisation for Economic Co-operation and Development (OECD): Framework for integrated analysis. OECD Framework for statistics on the distribution of household income, consumption and wealth 2013. www.doi.org/10.1787/9789264194830-en (last accessed on 14 July 2019).
29.DEBRA (the German Study on Tobacco Use): Materials of the DEBRA study. www.//osf.io/e2nqr/ (last accessed on 27 September 2019).
30.West R, Mohr G, Proudfoot H, Brown J: Top-line findings on smoking in England from the Smoking Toolkit Study. www.smokinginengland.info (last accessed on 19 September 2019).
31.Beard E, Jackson SE, West R, Kuipers MAG, Brown J: Trends in attempts to quit smoking in England since 2007: a time series analysis of a range of population-evel influences. Nicotine Tob Res 2019; pii: ntz141. doi: 10.1093/ntr/ntz141 [Epub ahead of print] CrossRef MEDLINE
32.Kotz D, Fidler J, West R: Factors associated with the use of aids to cessation in English smokers. Addiction 2009; 104: 1403–10 CrossRef MEDLINE
33.Kotz D, Willemsen M, Brown J, West R: Light smokers are less likely to receive advice to quit from their GP than moderate-to-heavy smokers: a comparison of national survey data from the Netherlands and England. Eur J Gen Pract 2013; 19: 99–105 CrossRef MEDLINE
34.Kastaun S, Kotz D: [Brief physician advice for smoking cssation: results of the DEBRA study]. SUCHT 2019; 65: 34–41 CrossRef
35.Fernández E, Lugo A, Clancy L, Matsuo K, La Vecchia C, Gallus S: Smoking dependence in 18 European countries: hard to maintain the hardening hypothesis. Prev Med 2015; 81: 314–9 CrossRef MEDLINE
36.John U, Meyer C, Hapke U, Rumpf H-J, Schumann A: Nicotine dependence, quit attempts, and quitting among smokers in a regional population sample from a country with a high prevalence of tobacco smoking. Prev Med 2004; 38: 350–8 CrossRef MEDLINE
37.Berg CJ, An LC, Kirch M, et al.: Failure to report attempts to quit smoking. Addict Behav 2010; 35: 900–4 CrossRef MEDLINE
38.Borland R, Partos TR, Cummings KM: Systematic biases in cross-sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine Tob Res 2012; 14: 1483–7 CrossRef MEDLINE PubMed Central